CBD for depression - 13 research studies | cannabisMD

CBD for Depression – 13 Research Studies

CBD for Depression - 13 Research Studies

Credit: The Mental Health Herbalist

Dr. Tom Brien who goes by The Mental Health Herbalist, wants to educate matters on medicinal and herbal plants to improve overall health and well-being.

In this video, Tom discusses the topic of CBD oil and 13 studies that are known to improve depression.

Tom states that The irish government conducted a scientific review on cannabis and its medicinal uses. In the review they found that there was insufficient evidence of pharmaceutical grade cannabis to show results. From this review, Tom believes that the link between the Irish government, the medical profession and the large pharmaceutical companies aim to control the overall production of medicinal cannabis.

Dr. Brien states that a subscriber of his reached out to him about his back story with medicinal cannabis and had sent Tom a testimonial. The subscriber stated that he had suffered with depression, he received many depressive symptoms such as weight gain and fatigue. He set out to change his lifestyle, he had taken the medication prescribed by a doctor, but claimed that it had really bad side effects, and due to these side effects, he began to explore different herbs and remedies to aid his depression when he came across CBD oil, and said that his depression was inexistent, with no side-effects.

In the testimonial that the subscriber sent, it included 13 different studies in relation to CBD oil that set out to cure depression. The studies where:

  • Endocannabinoid system dysfunction in mood and related disorders.
  • Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.
  • The endocannabinoid system and the treatment of mood and anxiety disorders.
  • Endocannabinoid signaling in the etiology and treatment of major depressive illness
  • Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.
  • Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
  • Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
  • Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
  • Serum contents of endocannabinoids are correlated with blood pressure in depressed women
  • The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
  • Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
  • Prohedonic Effect of Cannabidiol in a Rat Model of Depression.
  • Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *